LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in ELAN — Elanco Animal Health Inc
CIK 932974
BOSTON, MA
Position in ELAN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$130,186
+$125,434 QoQ
Shares Held
5,290
+2419.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#382
of 515 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $1,097,583 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (11.9% of the industry book) .
All Filings in ELAN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $130,186 | 5,290 | Shares | Sole | 2026-07-30 | |
| 2025-12-31 | $4,752 | 210 | Shares | Sole | 2026-01-28 | |
| 2023-12-31 | $4,559 | 306 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,439 | 306 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,078 | 306 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,038 | 536 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $6,549 | 536 | Shares | Sole | 2023-03-02 | |
| 2022-09-30 | $6,651 | 536 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $10,521 | 536 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $13,984 | 536 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $15,211 | 536 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,093 | 536 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $18,593 | 536 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $16,439 | 536 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $14,970 | 536 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $11,497 | 536 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $12,001 | 536 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||